Biologics | Yale Ventures

Biologics

Flavell Head Shot

A therapeutic calcium channel blocking antibody for cancer

Issacs Head Shot

Biosynthesis of therapeutic GLP-1 peptides

Development of a novel, phosphospecific alpha-synuclein antibody as a therapeutic for MSA

Pusztai Head Shot

First-in-class Nectin-2 targeting ADC for solid tumors

RNAConnect

RNAConnect

Braddock Head Shot

Targeting genetically associated childhood and adult obesity

Arya

Generation of a humanized antibody with a proven effect for the prevention of Thoracic and abdominal Aortic aneurysm Dissection in mice

MARTIN

Therapeutic targeting of protocadherin gamma A9 (Pcdhga9)

Seth Herzon

DNA Self-Activating Warheads (SAWs)

Jose

Targeting Non-Tuberculous Mycobacteria with AI-Designed Antimicrobial Peptides

Subscribe to Biologics